Gates Foun­da­tion backs a new sick­le cell CRISPR ap­proach; Sid­dhartha Mukher­jee's Vor adds a new CAR-T

CRISPR/Cas9 play­er In­tel­lia Ther­a­peu­tics has a new backer — the Bill and Melin­da Gates Foun­da­tion.

The char­i­ty is spon­sor­ing re­search for in vi­vo sick­le cell dis­ease …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER